Gen.Orph Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2ndary - Private

Gen.Orph General Information

Description

Developer of generic orphan drugs designed to treat rare diseases in children. The company's drugs offer patients and medical teams worldwide generic orphan medicines that are affordable and effective at curing rare diseases as well as drugs that are neglected by the pharmaceutical industry despite their medical efficiency, enabling patients to get treatment for rare diseases at affordable costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 1 rue royale
  • Saint-Cloud
  • 92210 Paris
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gen.Orph Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Oct-2021 00.000 Completed Generating Revenue
3. Later Stage VC 01-Apr-2020 00.000 00.000 00.000 Completed Generating Revenue
2. Later Stage VC 16-Feb-2017 $642K $2.7M 00.000 Completed Generating Revenue
1. Early Stage VC 01-Jan-2014 $2.06M $2.06M 00.000 Completed Generating Revenue
To view Gen.Orph’s complete valuation and funding history, request access »

Gen.Orph Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class C 0,000 0000.000000 0000.00 0000.00 00 0000.00 00.000
Class C 000 0000.000000 0000.00 0000.00 00 0000.00 00.00
To view Gen.Orph’s complete cap table history, request access »

Gen.Orph Executive Team (3)

Name Title Board Seat Contact Info
Etienne Jacob MD Co-Founder, President and Chief Executive Officer
Eric Lille Chief Financial Officer
Patrice Layrac Co-Founder & Board Member
To view Gen.Orph’s complete executive team members history, request access »

Gen.Orph Board Members (1)

Name Representing Role Since
Patrice Layrac Gen.Orph Co-Founder & Board Member 000 0000
To view Gen.Orph’s complete board members history, request access »

Gen.Orph Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gen.Orph FAQs

  • When was Gen.Orph founded?

    Gen.Orph was founded in 2012.

  • Who is the founder of Gen.Orph?

    Etienne Jacob MD and Patrice Layrac are the founders of Gen.Orph.

  • Who is the CEO of Gen.Orph?

    Etienne Jacob MD is the CEO of Gen.Orph.

  • Where is Gen.Orph headquartered?

    Gen.Orph is headquartered in Paris, France.

  • What is the size of Gen.Orph?

    Gen.Orph has 12 total employees.

  • What industry is Gen.Orph in?

    Gen.Orph’s primary industry is Drug Discovery.

  • Is Gen.Orph a private or public company?

    Gen.Orph is a Private company.

  • What is Gen.Orph’s current revenue?

    The current revenue for Gen.Orph is 00000.

  • How much funding has Gen.Orph raised over time?

    Gen.Orph has raised $3.72M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »